Compared to group A, serum IL-1β, TNF-α, and PGE2 levels were significantly lower in group B (p < 0.05), indicating that THD could improve the inflammation level in the serum of LSS patients (Figure 2). The gene discussed is IL1B; the disease is Leigh syndrome.